These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16325002)

  • 1. Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age.
    Torres EM; Monville C; Lowenstein PR; Castro MG; Dunnett SB
    Brain Res Bull; 2005 Dec; 68(1-2):31-41. PubMed ID: 16325002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M; Cutillas B; Arenas TE; Ambrosio S
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells.
    Apostolides C; Sanford E; Hong M; Mendez I
    Neuroscience; 1998 Mar; 83(2):363-72. PubMed ID: 9460746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compacted DNA nanoparticle gene transfer of GDNF to the rat striatum enhances the survival of grafted fetal dopamine neurons.
    Yurek DM; Flectcher AM; Kowalczyk TH; Padegimas L; Cooper MJ
    Cell Transplant; 2009; 18(10):1183-96. PubMed ID: 19650971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor.
    Krobert K; Lopez-Colberg I; Cunningham LA
    Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
    Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
    Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson's disease.
    Torres EM; Dowd E; Dunnett SB
    Neuroscience; 2008 Jun; 154(2):631-40. PubMed ID: 18468807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease.
    Torres EM; Monville C; Gates MA; Bagga V; Dunnett SB
    Neuroscience; 2007 Jun; 146(4):1606-17. PubMed ID: 17478050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulation of young donor age dopaminergic grafts in a GDNF-loaded collagen hydrogel further increases their survival, reinnervation, and functional efficacy after intrastriatal transplantation in hemi-Parkinsonian rats.
    Moriarty N; Cabré S; Alamilla V; Pandit A; Dowd E
    Eur J Neurosci; 2019 Feb; 49(4):487-496. PubMed ID: 30054941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine cells in nigral grafts differentiate prior to implantation.
    Sinclair SR; Fawcett JW; Dunnett SB
    Eur J Neurosci; 1999 Dec; 11(12):4341-8. PubMed ID: 10594660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
    Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
    Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease.
    Tereshchenko J; Maddalena A; Bähr M; Kügler S
    Neurobiol Dis; 2014 May; 65():35-42. PubMed ID: 24440408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons.
    Haque NS; LeBlanc CJ; Isacson O
    Cell Transplant; 1997; 6(3):239-48. PubMed ID: 9171157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-grafts of fetal ventral mesencephalon and fibroblasts expressing sonic hedgehog: effect on survival and function of dopamine grafts.
    Yurek DM; Fletcher-Turner A; Moore J; Chai L; Mahanthappa N
    Cell Transplant; 2001; 10(8):665-71. PubMed ID: 11814108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fetal mesencephalic grafts, AAV-delivered GDNF, and both combined in an MPTP-induced nonhuman primate Parkinson's model.
    Redmond DE; McEntire CR; Kingsbery JP; Leranth C; Elsworth JD; Bjugstad KB; Roth RH; Samulski RJ; Sladek JR
    Mol Ther; 2013 Dec; 21(12):2160-8. PubMed ID: 23913185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
    Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
    Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.
    Lapchak PA; Araujo DM; Hilt DC; Sheng J; Jiao S
    Brain Res; 1997 Nov; 777(1-2):153-60. PubMed ID: 9449424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.